Human
beta-endorphin (1-31) (beta
H-endorphin) was found to specifically interact with purified
complement S protein from human plasma. As found by chemical cross-linking beta
H-endorphin bound to both, the 65- and 75-kDa molecular mass forms of S
protein. The interaction of S
protein with
heparin as well as the adsorption of S
protein to surfaces led to an almost 10-fold increase of specific binding which was due to the exposure of further beta
H-endorphin-binding sites. The interaction of beta
H-endorphin with S
protein bore characteristics of a
ligand-receptor interaction, such as time dependence, reversibility, high affinity, saturability, and structural specificity and was mediated through the non-
opioid COOH terminus of the beta
H-endorphin molecule. beta
H-Endorphin binding to S
protein was observed at physiological pH or
cation concentrations, indicating that the interaction may well occur in vivo. Our results provide conclusive evidence that interactions of S
protein with very different effectors led to similar conformational changes which uniformly resulted in exposure of a highly specific beta
H-endorphin binding domain on S
protein. With S
protein as major beta
H-endorphin-
binding protein in the periphery, the molecular basis of a widespread system of humoral target sites of the neuroendocrine effector appears to be established. In view of S
protein involvement in processes of
inflammation and
wound repair and
beta-endorphin effects on immunocompetent cells, the demonstrated S
protein-beta
H-endorphin interaction appears to be of considerable functional significance.